58 related articles for article (PubMed ID: 20087864)
1. Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.
Lacroix J; Leuchs B; Li J; Hristov G; Deubzer HE; Kulozik AE; Rommelaere J; Schlehofer JR; Witt O
Int J Cancer; 2010 Sep; 127(5):1230-9. PubMed ID: 20087864
[TBL] [Abstract][Full Text] [Related]
2. The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.
Mazar J; Brooks JK; Peloquin M; Rosario R; Sutton E; Longo M; Drehner D; Westmoreland TJ
Cancer Res Commun; 2024 Jan; 4(1):65-80. PubMed ID: 38214542
[TBL] [Abstract][Full Text] [Related]
3. Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.
Vollmers EM; Tattersall P
Virology; 2013 Nov; 446(1-2):37-48. PubMed ID: 24074565
[TBL] [Abstract][Full Text] [Related]
4. The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.
Angelova A; Rommelaere J; Ungerechts G
Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535528
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
Turnbull S; West EJ; Scott KJ; Appleton E; Melcher A; Ralph C
Viruses; 2015 Dec; 7(12):6291-312. PubMed ID: 26633468
[TBL] [Abstract][Full Text] [Related]
6. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
[TBL] [Abstract][Full Text] [Related]
7. Design and Characterization of Mutated Variants of the Oncotoxic Parvoviral Protein NS1.
Hauswirth P; Graber P; Buczak K; Mancuso RV; Schenk SH; Nüesch JPF; Huwyler J
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680249
[TBL] [Abstract][Full Text] [Related]
8. Progress of oncolytic virotherapy for neuroblastoma.
Chen XT; Dai SY; Zhan Y; Yang R; Chen DQ; Li Y; Zhou EQ; Dong R
Front Pediatr; 2022; 10():1055729. PubMed ID: 36467495
[TBL] [Abstract][Full Text] [Related]
9. Adding recombinant AAVs to the cancer therapeutics mix.
Mulcrone PL; Herzog RW; Xiao W
Mol Ther Oncolytics; 2022 Dec; 27():73-88. PubMed ID: 36321134
[TBL] [Abstract][Full Text] [Related]
10. Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.
Hanisch D; Krumm A; Diehl T; Stork CM; Dejung M; Butter F; Kim E; Brenner W; Fritz G; Hofmann TG; Roos WP
Cell Death Dis; 2022 Apr; 13(4):293. PubMed ID: 35365623
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review).
Sevastre AS; Costachi A; Tataranu LG; Brandusa C; Artene SA; Stovicek O; Alexandru O; Danoiu S; Sfredel V; Dricu A
Exp Ther Med; 2021 Dec; 22(6):1408. PubMed ID: 34676001
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry.
Kulkarni A; Ferreira T; Bretscher C; Grewenig A; El-Andaloussi N; Bonifati S; Marttila T; Palissot V; Hossain JA; Azuaje F; Miletic H; Ystaas LAR; Golebiewska A; Niclou SP; Roeth R; Niesler B; Weiss A; Brino L; Marchini A
Nat Commun; 2021 Jun; 12(1):3834. PubMed ID: 34158478
[TBL] [Abstract][Full Text] [Related]
13. Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors.
Oh CM; Chon HJ; Kim C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086754
[TBL] [Abstract][Full Text] [Related]
14. Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
Mazar J; Li Y; Rosado A; Phelan P; Kedarinath K; Parks GD; Alexander KA; Westmoreland TJ
PLoS One; 2018; 13(7):e0200358. PubMed ID: 30044847
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo.
Lacroix J; Kis Z; Josupeit R; Schlund F; Stroh-Dege A; Frank-Stöhr M; Leuchs B; Schlehofer JR; Rommelaere J; Dinsart C
Viruses; 2018 Jun; 10(6):. PubMed ID: 29865280
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.
Geiss C; Kis Z; Leuchs B; Frank-Stöhr M; Schlehofer JR; Rommelaere J; Dinsart C; Lacroix J
Viruses; 2017 Oct; 9(10):. PubMed ID: 29039746
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.
Geletneky K; Hajda J; Angelova AL; Leuchs B; Capper D; Bartsch AJ; Neumann JO; Schöning T; Hüsing J; Beelte B; Kiprianova I; Roscher M; Bhat R; von Deimling A; Brück W; Just A; Frehtman V; Löbhard S; Terletskaia-Ladwig E; Fry J; Jochims K; Daniel V; Krebs O; Dahm M; Huber B; Unterberg A; Rommelaere J
Mol Ther; 2017 Dec; 25(12):2620-2634. PubMed ID: 28967558
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain.
Takenouchi A; Saito K; Saito E; Saito T; Hishiki T; Matsunaga T; Isegawa N; Yoshida H; Ohnuma N; Shirasawa H
Pediatr Surg Int; 2015 Dec; 31(12):1151-9. PubMed ID: 26298056
[TBL] [Abstract][Full Text] [Related]
19. Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.
Angelova AL; Geletneky K; Nüesch JP; Rommelaere J
Front Bioeng Biotechnol; 2015; 3():55. PubMed ID: 25954743
[TBL] [Abstract][Full Text] [Related]
20. Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1.
Geletneky K; Leoni AL; Pohlmeyer-Esch G; Loebhard S; Baetz A; Leuchs B; Roscher M; Hoefer C; Jochims K; Dahm M; Huber B; Rommelaere J; Krebs O; Hajda J
Comp Med; 2015 Feb; 65(1):23-35. PubMed ID: 25730754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]